Saol boards FDA’s resubmission boat, armed with new survival data
Saol Therapeutics is the latest biotech to resubmit for approval of a drug rejected under former FDA Commissioner Marty Makary, following REGENXBIO and Replimune.
Read the full articleYou might also wanna read
Medicinal plants used to treat infectious diseases in French Polynesia: an ethnobotanical survey and antibacterial evaluation
archimer.ifremer.fr·just now
A standardized method to monitor marine litter in submarine canyons: implementation in Atlantic and Mediterranean reef ecosystems
archimer.ifremer.fr·just now
Women in Nonequilibrium Statistical Physics, 7–11 Sep 2026 at KU Leuven (Belgium).
fys.kuleuven.be·just now
Oceanographic parameters associated with spatial occurrence of cephalopods in standardized demersal fishing trawls in the NE Atlantic
archimer.ifremer.fr·just now
BPI Asia Digital Series
bioprocessintl.com·just now
Israel’s Beresheet lander crashed into the Moon in 2019 carrying several thousand tardigrades in a dehydrated, dormant state—and although later experiments suggest they probably did not survive the impact, nobody knows whether any remain intact enough to
Space Daily·15m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.